Clinical Trial Detail

NCT ID NCT03512756
Title A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tyme, Inc
Indications

pancreatic adenocarcinoma

Therapies

Methoxsalen + Phenytoin + Sirolimus + SM88

Gemcitabine

Fluorouracil

Capecitabine

Age Groups: adult senior

No variant requirements are available.